{
    "clinical_study": {
        "@rank": "104297", 
        "biospec_descr": {
            "textblock": "whole blood, plasma, isolated leukocytes, skeletal muscle, fat, skin"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine important and significant problems, that of insulin\n      resistance and muscle wasting after burn injury."
        }, 
        "brief_title": "Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Burn", 
        "condition_browse": {
            "mesh_term": [
                "Burns", 
                "Insulin Resistance"
            ]
        }, 
        "detailed_description": {
            "textblock": "Burn injury induces insulin resistance and our investigators have previous shown the\n      importance of insulin receptor substrate 1 (IRS-1)-mediated pathways.  This project will\n      establish the inhibitory effects of burn injury on IRS-1 mediated signaling in human\n      skeletal muscle of burn patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Burn injury >=10% total body surface area involvement from any etiology that will\n             require surgical treatment\n\n          -  Age 18 years or older\n\n          -  Admitted to the Massachusetts General Hospital within 30 days of burn injury\n\n          -  Patient or guardian who is capable of giving full informed consent\n\n        Exclusion Criteria:\n\n          -  Decision not to treat due to severity of injury\n\n          -  Presence of anoxic brain injury that is not expected to result in complete recovery\n\n          -  Existence of co-morbid conditions of malignancy currently under treatment, medical\n             condition requiring glucocorticoid treatment, insulin dependent diabetes mellitus,\n             morbid obesity defined as body mass index >= 40"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Massachusetts General Hospital (MGH) burn patients from the emergency department,\n        intensive care unit, burn unit, or other MGH inpatient unit"
            }
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02029261", 
            "org_study_id": "P50GM021700P4_1", 
            "secondary_id": "2P50GM021700-32A1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Burn", 
        "lastchanged_date": "January 6, 2014", 
        "link": {
            "description": "MGH Burn Research Center", 
            "url": "http://www.burnresearchcenter.org/brcpublicwebsite/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "Massachusetts General Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Project 4: Molecular Mechanisms in Burn-induced Insulin Resistance in Humans", 
        "overall_contact": {
            "email": "yyu@mgh.harvard.edu", 
            "last_name": "Yong-Ming Yu, MD, PhD", 
            "phone": "617-371-4864"
        }, 
        "overall_official": {
            "affiliation": "Massachusetts General Hospital", 
            "last_name": "Ronald G Tompkins, MD, ScD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Determination of individual profiles and comparison with profiles from existing patients and healthy controls", 
            "measure": "Determination of gene expression profile and protein expression", 
            "safety_issue": "No", 
            "time_frame": "Time of burn injury up to 24 months postinjury"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02029261"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Institute of General Medical Sciences (NIGMS)", 
            "investigator_full_name": "Dr. Ronald G Tompkins", 
            "investigator_title": "Chief, Burns Division", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Alive or dead", 
                "measure": "Hospital discharge status", 
                "safety_issue": "No", 
                "time_frame": "From hospital admission to discharge"
            }, 
            {
                "description": "Analysis of incidence of clinical complications related to organ function/dysfunction", 
                "measure": "Presence of clinical complications", 
                "safety_issue": "No", 
                "time_frame": "From hospital admission to discharge"
            }, 
            {
                "description": "Total number of ICU days", 
                "measure": "Intensive care unit (ICU) days", 
                "safety_issue": "No", 
                "time_frame": "From hospital admission to discharge"
            }, 
            {
                "description": "Analysis of change in total body weight, lean body mass, indirect calorimetry, and nitrogen balance", 
                "measure": "Nutritional status at discharge", 
                "safety_issue": "No", 
                "time_frame": "At hospital discharge"
            }, 
            {
                "description": "Gene and and protein expression data will be correlated with the physiological and and in vivo physiologic measurements (lab values) and nutritional status data.", 
                "measure": "Correlation between protein data and in vivo physiologic measurement data", 
                "safety_issue": "No", 
                "time_frame": "Hospitalization"
            }
        ], 
        "source": "National Institute of General Medical Sciences (NIGMS)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of General Medical Sciences (NIGMS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}